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Abstract 
 
One of the hallmarks of cancer is chromosome instability (CIN), which leads to aneuploidy, 
translocations and other chromosome aberrations. However, in the vast majority of human tumors the 
molecular basis of CIN remains unknown, partially because not all genes controlling chromosome 
transmission have yet been identified. To address this question, we have developed an experimental high-
throughput imaging (HTI) siRNA assay that allows the identification of novel CIN genes. Our method 
uses a human artificial chromosome (HAC) expressing the GFP transgene. When this assay was applied 
to screen a siRNA library of protein kinases we identified PINK1, TRIO, IRAK1, PNCK, and TAOK1 as 
potential novel genes whose knockdown induces various mitotic abnormalities and results in chromosome 
loss. The HAC-based assay can be applied for screening different siRNA libraries (cell cycle regulation, 
DNA damage response, epigenetics, transcription factors) to identify additional genes involved in CIN. 
Identification of the complete spectrum of CIN genes will reveal new insights into mechanisms 
of chromosome segregation and may expedite the development of novel therapeutic strategies to target 
the CIN phenotype in cancer cells. 
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Introduction 
 
Chromosome instability (CIN), involving the unequal distribution of chromosomes to daughter cells 
during mitosis, is observed in the majority of solid tumors (Thompson et al. 2010). CIN may be caused by 
mutations in or mis-regulation of a specific set of genes. These so-called “CIN” genes encode components 
that control DNA replication, the mitotic checkpoint and chromosome segregation. Mutations in CIN 
genes are thought to often be an early event in tumor development predisposing cells to the accumulation 
of genetic changes promoting the transition to a cancerous state (Thompson et al. 2010). Conversely, 
recent findings indicate that because cancer cells often lack protective pathways,  CIN may be also a 
barrier to tumor growth and, therefore, can be exploited therapeutically (Janssen et al. 2009; Swanton et 
al. 2009).  
Currently, approximately 400 human genes are annotated with Gene Ontology (GO) terms 
associated with proper chromosomal transmission, while systematic CIN gene screens in the yeast 
Saccharomyces cerevisiae have revealed 692 genes (Stirling et al. 2011; Stirling et al. 2012). Recently, 
245 additional genes whose individual overexpression causes CIN were identified in yeast. These genes 
were referred to as dosage CIN (dCIN) genes (Duffy et al. 2016). Thus, the combined catalog of yeast 
genes contributing to chromosome instability consists of 937 genes. The published yeast CIN gene list 
suggests that many biological processes are involved in the protection of genome integrity. A large 
proportion of CIN genes functions in expected pathways such as in mitosis, DNA replication and repair, 
but some act in biological pathways with unknown connections to chromosome segregation (e.g., tRNA 
synthesis, GPI- anchors and secretion) (Yuen et al. 2007; Stirling et al. 2011; Stirling et al. 2012). 
Because over 60% of baker’s yeast genes are clearly conserved across diverse organisms including 
humans, approximately 400 CIN genes in yeast have orthologues in the human genome (Stirling et al. 
2012; Duffy et al. 2016). Characterization of these genes in human cells may offer a first step towards 
completing the annotation of genetic loci controlling chromosome transmission.  
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Genome-wide siRNA screens have been used to interrogate a variety of molecular mechanisms 
related to increased sensitivity to ionizing radiation or spontaneous gamma H2AX (phosphorylated 
histone H2AX at serine 139) (Paulsen et al. 2009; Hurov et al. 2010). In a landmark study, the MitoCheck 
Consortium carried out a genome-wide phenotypic siRNA screen against ~21,000 human genes using live 
imaging of fluorescently labeled chromosomes (Hutchins et al. 2010; Neumann et al. 2010). However, a 
systematic siRNA screen of yeast orthologues in the human genome to identify novel CIN genes has not 
been performed yet. This may be in part because unequal distribution of chromosomes to daughter cells is 
currently monitored only through laborious assays, involving karyotype analysis or fluorescent in situ 
hybridization (FISH). 
In the current study, we developed a novel high-throughput imaging (HTI) siRNA assay to 
identify unknown human CIN genes. This assay is based on a non-essential human artificial chromosome 
(HAC) expressing a short half-life green fluorescent protein (GFP). This HAC, like other HACs, follows 
the rules of mitosis and chromosome segregation just like the natural chromosomes during the cell cycle 
progression (Nakano et al. 2008; Bergmann et al. 2012; Ohzeki et al. 2015; Molina et al. 2017). It is 
worth noting that the use of yeast artificial chromosomes (YACs) was critical for the discovery and 
systematic analysis of CIN genes in S. cerevisiae (Maine et al. 1984; Spencer et al. 1990; Kouprina et al. 
1993; Roberts et al. 1994). We used this novel HAC-based HTI assay to screen a siRNA library targeting 
human kinases and known yeast CIN orthologues and identified several genes, knockdown of which 
induces chromosome instability. The discovery of a comprehensive list of CIN genes will shed light on 
the mechanisms of chromosome transmission and should expedite the development of novel therapeutic 




Experimental system to identify novel human genes controlling proper chromosome transmission 
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To identify CIN genes, we developed a novel high-throughput imaging (HTI) assay that is based on the 
use of an alphoidtetO-HAC (Nakano et al. 2008) carrying a dual cassette simultaneously expressing two 
destabilized versions of the GFP transgene. This HAC, which was assembled from centromeric repeats 
contains a functional centromere that allows its relatively stable inheritance as a nonessential 
chromosome. The HAC loss rate  is roughly 10-fold higher when compared the native chromosomes 
(Nakano et al. 2008) that makes the assay very sensitized and allows to see a statistically significant 
number of events in a realistic sample size when studying the CIN phenotype in human cells. Previously 
the HAC was utilized for low-throughput identification of drugs that elevate chromosome instability 
(CIN) in cancer cells (Lee et al. 2013a; Kim et al. 2016; Lee et al. 2016), as a gene delivery vector for the 
efficient and regulated expression of exogenous full-length genes in mammalian cells (Iida et al. 2010; 
Kim et al. 2011; Kouprina et al. 2012; Kouprina et al. 2013; Kononenko et al. 2014; Kouprina et al. 2014; 
Liskovykh et al. 2015; Lee et al. 2018) and for studies of the epigenetic regulation of human kinetochores 
(Bergmann et al. 2012; Ohzeki et al. 2015; Molina et al. 2017).  
In the current study, we hypothesized that siRNA dependent knockdown of the genes that are 
essential for proper transmission of natural human chromosomes would induce HAC loss. To develop the 
assay, the plasmid p264-GFP-CDT1-GFP-GEMININ was constructed (Supplemental Fig. S1) containing 
two modified short half-life green fluorescent transgenes. More precisely, the plasmid encodes two 
fusions of GFP: GFP-fused with a 30-120 amino acid domain of CDT1 and GFP-fused with a 1-110 
amino acid domain of Geminin. CDT1 and Geminin are the marker-proteins for different cell cycle stages 
(Supplemental Movie S1) (Sakaue-Sawano et al. 2008). The GFP-CDT1 fusion will cause the HAC-
containing cells to be green in the G1 phase of the cell cycle. The GFP-GEMININ fusion causes the HAC 
containing cells to be green in the S-G2-M phases of the cell cycle (Fig. 1A, B). Thus, the cells carrying 
the HAC/dGFP should show a robust fluorescent signal in the GFP channel throughout the cell cycle 
(Supplemental Movie S2) and lose the GFP signal within hours after HAC loss. We called this class of 
GFP-fusions “destabilized GFP” (or dGFP). The p264-GFP-CDT1-GFP-GEMININ plasmid was inserted 
into the single loxP site of an alphoidtetO-HAC in hamster CHO cells by Cre-lox-mediated recombination 
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producing HAC/dGFP which was then transferred via MMCT to the human HT1080 fibrosarcoma cell 
line (Fig. 1A and Supplemental Fig. S2).  
We predicted two outcomes after siRNA treatment: -1- no change in the percentage of GFP 
expressing cells (no effect on HAC stability) or, -2- an increase in the percentage of GFP-negative cells if 
siRNAs induce chromosome segregation errors (Fig. 1C). Control untreated cells containing HAC/dGFP 
should show uniform green fluorescence. Rapid loss of the GFP signal is critical because loss of 
fluorescence in the GFP channel after mitosis will allow detection of HAC loss within 72-96 hours after 
siRNA treatment or 9 hours after HAC loss. The number of cells without the HAC can be measured using 
high-throughput imaging (HTI) screening (Fig. 1D). In comparison, the use of the standard GFP 
transgene for the same purpose is not applicable due to the protein’s long half-life (Lee et al. 2016). In 
this case the cells remain green although a target gene is knockdown and HAC is lost, which makes 
impossible to use a high-throughput imaging approach. We next set out to test whether the HAC/dGFP-
HTI assay can be applied to screen libraries of siRNAs to identify human genes whose knockdown results 
in chromosome instability.  
 
Effect on mitotic stability of HAC/dGFP of siRNA-mediated knockdown of human genes known to 
be essential for chromosomal transmission 
 
To identify an appropriate positive control for our assay, we carried out experiments to assess the 
behavior of the HAC/dGFP-HTI assay following the knockdown of genes essential for kinetochore 
function. We chose six genes, i.e. CENPA encoding the centromere-specific histone H3 variant CENPA 
(Fukagawa and Earnshaw 2014), CENPN which participate in the centromeric nucleosome recognition 
(Carroll et al. 2009), CENPE encoding the mitotic centromeric kinesin which participates in microtubule 
capture (Sardar and Gilbert 2012), AURKB encoding the chromosome segregation kinase which forms the 
chromosomal passenger complex (CPC) (Carmena et al. 2012), OIP5 encoding the CENPA deposition 
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factor which regulates recruitment of the OIP5 complex to centromeres (Stellfox et al. 2016) and SKA3 
encoding an outer kinetochore protein implicated in microtubule binding (Sivakumar et al. 2014).  
Mitotic stability of the HAC/dGFP in HT1080 human cells transfected with siRNAs against 
either CENPA, CENPN, CENPE, AURKB, OIP5, or SKA3 was measured by three independent 
techniques: flow cytometry (FACS), high-throughput imaging (HTI) and fluorescence in situ 
hybridization (FISH) (Fig. 2A,B,C,D). The level of each protein reduction was monitored by Western blot 
analysis (Fig. 2E; Supplemental Table S8). Knockdown of OIP5 and SKA3 showed the strongest effect, 
with significant HAC/dGFP loss at 96 hours after siRNA transfection. Following these experiments, 
siRNAs against SKA3 and OIP5 were used as positive controls; more specifically, SKA3 for siRNA 
screening (HTI) and OIP5 for FACS experiments.  
 
A pilot siRNA screen of human orthologues of yeast CIN genes identifies a gene encoding protein 
kinase PRKCΕ 
 
937 CIN genes have been identified in large-scale screens for chromosome instability in yeast (Stirling et 
al. 2011; Stirling et al. 2012; Duffy et al. 2016). Most of these genes function in biological pathways 
whose mechanism of action on chromosome transmission is as yet unknown. A large number of these 
CIN genes have human orthologs  (Stirling et al. 2012; Duffy et al. 2016), making them good candidates 
for discovery of new pathways controlling human genome stability.  
Among known yeast CIN genes, we chose 28 human orthologs belonging to different functional 
categories and for which siRNA-mediated knockdown in human cells have been previously reported 
(Supplemental Table S1). This allowed us to use the verified siRNAs for cell treatment. The gene 
orthologs selected for the analysis were: CNOT6, NAT10, PIGB, TANGO6, PIGU, PIGS, GPN2, PRC1, 
IPO11, CIAO2B, NPEPPS, RTN2, UAP1, MSI1, AP2B1, PPIP5K1, WDR76, C12orf10, PLCD3, MUC4, 
NF1, RAB1A, MEMO1, SMARCAD1, RPL13, XAB2, MYO5B, and PRKCΕ. They are orthologs of yeast 
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proteins whose down-regulation in yeast leads to chromosomal instability (Sterling et al. 2011; Stirling et 
al. 2012). 
Figure 3 shows the rate of HAC/dGFP loss per generation in response to the siRNA knockdown 
of the above human genes.  Mitotic stability of HAC/dGFP was measured by FACS (Fig. 3A) and HTI 
(Fig. 3B). Silencing efficiency of the proteins was monitored by Western blot analysis (Fig. 3C; 
Supplemental Table S8). Among 28 siRNA knockdowns analyzed, only the knockdown of PRKCΕ 
induced a significant increase in HAC/dGFP loss. PRKCΕ is an ortholog of yeast PKC1, which is 
required for yeast cell growth and division (Levin 2005). A failure to detect HAC/dGFP loss after siRNA-
mediated knockdown of other genes does not exclude that some of them may be involved in CIN. This 
can be explained by: either i) a high cytotoxic effect of these siRNAs, i.e. the treated cells die faster than 
they can show any effect on HAC loss, or ii) the extreme stability of the target proteins or iii) insufficient 
knockdown of a protein to the level that causes hypermorphic or loss of function for the assay being 
tested.  
The human PRKCΕ gene encodes Protein Kinase C-epsilon, which has a variety of functions in 
different cell types (Scruggs et al. 2016). Recently involvement of PRKCΕ in mitotic spindle organization 
was demonstrated (Brownlow et al. 2014; Martini et al. 2018). More specifically, PRKCΕ is involved in 
the control of prophase-to-metaphase progression by coordinating centrosome migration and mitotic 
spindle assembly (Martini et al. 2018). Because the role of most protein kinases in chromosome 
transmission is poorly investigated, we chose a siRNA library of human protein kinases for further 
experiments, using PRKCΕ siRNA as an internal positive control. 
 
Screening of an siRNA library reveals nine human protein kinases potentially involved in accurate 
chromosome transmission 
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 A siRNA library against 714 genes previously annotated as either kinases or phosphatases was used for 
analysis (Supplemental Fig. S3). In this arrayed library, each well contained a pool of four independent 
siRNAs targeting the same gene. We optimized the transfection conditions of the library to maximize cell 
viability while still maintaining efficient siRNA knockdown (i.e. gene down-regulation should not lead to 
cell death and the number of cells should be enough to permit statistically significant calculations), while 
still maintaining efficient siRNA knockdown efficiency (see Methods for details and Supplemental Fig. 
S4). In these experiments, SKA3 siRNA knockdown was used as a positive control. Figure 4A illustrates 
the distribution of siRNAs against protein kinases based on their Z-score (the absolute value of Z 
represents the distance between the raw score and the population mean in units of the standard deviation – 
see also Supplemental Fig. S4). In further analysis we focused on siRNAs that didn’t show high cytotoxic 
effects (Fig. 4B). Figure 4B shows the percentage of HAC/dGFP loss per cell division scored based on 
the proportion of GFP-negative cells (see Methods for details). Red asterisks indicate statistical 
significance (p<0.05) when compared to the negative control. Among 714 genes analyzed, the strongest 
effect on HAC/dGFP stability was detected after siRNA-mediated knockdown of the ITPKB, IRAK1, 
MYLK, TNK2, STK38, BLK, MAPK7, FRK, TRIO, STK11, CRIM1, CSK, PDXK, PHKG1, KSR2, 
CAMK2G, PHKB, CSNK1G2, TAOK1, MYLK4, NYD-SP25, RBKS, TTBK1, PNCK, PINK1, BTK, 
HIPK2, BUB1, ATM, BUB1B, PRKCE, TAOK1, and NEK9 genes. Silencing efficiency of the proteins 
was monitored by Western blot analysis (Fig. 4C; Supplemental Table S8). 
 Those 33 primary candidates were re-analyzed using independent siRNAs either found in the 
literature or made by the company (Supplemental Table S1). Figure 5A shows the comparison of the rates 
of HAC/dGFP loss for nine reconfirmed CIN candidate genes using three independent approaches: i) after 
siRNA-mediated knockdown using a pool of siRNAs from the library of human protein kinases (in 
brown); ii) after knockdown of each target gene using one independent siRNA (in blue); iii) the rate of 
HAC/dGFP loss was verified by FISH analysis (in green). The level of each protein reduction was 
monitored by Western blot analysis (Fig. 5B; Supplemental Table S8). After these experiments, a final 
list of the CIN candidates included the following genes: PINK1, STK38, TRIO, IRAK1, PNCK, TAOK1, 
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BUB1, BUB1B, and PRKCΕ (Supplemental Fig. S3 and Supplemental Table S2). It is worth noting that 
the human BUB1 and BUB1B genes are known to promote the spindle assembly checkpoint, which is 
important for proper chromosome transmission (Chan et al. 1999; Vleugel et al. 2015; Jia et al. 2016), and 
the STK38 gene is required for proper centrosome duplication, precise alignment of mitotic chromosomes 
and ensures proper spindle orientation in mitosis (Hergovich et al. 2007; Chiba et al. 2009; Yan et al. 
2015). Identification of these three genes along with PRKCΕ in the library supports the conclusion that 
the HAC/dGFP-HTI assay works adequately.  
 
Knockdown of PINK1, STK38, TRIO, IRAK1, PNCK, TAOK1, BUB1, BUB1B, and PRKCΕ genes 
leads to natural chromosome instability and an increased number of double-stranded breaks 
(DSBs) 
 
Micronucleus formation assays (MNi) have been extensively used to evaluate chromosome instability 
(Kirsch-Volders et al. 1997). In addition, formation of nucleoplasmic bridges (NPBs) is a sensitive 
measure of chromosome damage leading to chromosomal instability (Thomas et al. 2003). To investigate 
whether the knockdown of STK38, IRAK1, PINK1, PNCK, TAOK1, TRIO, PRKCΕ, BUB1, and BUB1B 
genes lead to instability of the natural chromosomes, we performed MNi and NPBs assays in non-
transformed retinal pigmented epithelial (RPE) cells. This assay revealed a significant difference in NPB 
formation between cells treated with scrambled siRNA (non-targeting) and the cells depleted for these 
genes (Fig. 6A,B,D). The percentage of NPBs after knockdown of STK38, IRAK1, PINK1, PNCK, TRIO, 
TAOK1, PRKCΕ, BUB1, and BUB1B genes was elevated compared to the negative control. The highest 
effect was observed for PINK1, STK38, and PRKCΕ genes (19-fold, 14-fold and 9-fold elevation, 
correspondingly) (Supplemental Table S3). Indeed, inhibition of PRKCΕ has previously been shown to 
result in chromosome bridging (Brownlow et al. 2014). In our experiments, we also measured the 
formation of MNi. The highest effect was observed for BUB1B, TRIO, PNCK, and BUB1 genes (30-fold, 
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25-fold, 14-fold and 12-fold elevation, correspondingly) (Fig. 6A,C,D and Supplemental Table S3). 
When the same experiments were performed in human fibrosarcoma HT1080 cells, the percentage of 
NPBs formation was elevated after knockdown of all nine of these proteins compared to the control 
(Supplemental Fig. S5A,C and Supplemental Table S4). The percentage of MNi formation was also 
elevated after knockdown of these genes except for TRIO compared to the control (Supplemental Fig. 
S5A,B and Supplemental Table S4).  
The elevated frequencies of binucleated cells with MNi and NPBs (measures of genome damage 
and chromosomal instability) support the hypothesis that PINK1, TRIO, IRAK1, TAOK1, and PNCK gene 
products are required for accurate chromosome transmission. Identification of BUB1, BUB1B, STK38 and 
PRKCΕ genes, which were previously known to be involved in proper chromosome transmission (Chan et 
al. 1999; Vleugel et al. 2015; Jia et al. 2016; Martini et al. 2018; Hergovich et al. 2007; Chiba et al. 
2009), in these experiments strongly supports the utility of the HAC/dGFP-HTI assay for screening new 
CIN genes.  
To determine whether the observed chromosome instability was accompanied by an increased 
number of double-stranded breaks (DSBs), we stained RPE cells after knockdown of PINK1, STK38, 
IRAK1, PNCK, TAOK1, TRIO, PRKCΕ,  BUB1, and BUB1B genes with an antibody against 
phosphorylated histone gamma H2AX. A statistically significant increase of gamma H2AX foci in 
interphase was observed after knockdown of the four genes, PINK1, TRIO, STK38, and BUB1 (Fig. 
6E,F). The strongest effect was observed after knockdown of PINK1 (20% cells) compared to control 
levels of DNA damage in RPE cells (less than 3%). Thus, in RPE cells chromosome instability after 
knockdown of PINK1, TRIO, STK38, BUB1, and BUB1B genes is accompanied by induction of DSBs. 
On the contrary, the number of H2AX foci in HT1080 cells changed little after siRNA knockdown of the 
same genes, possibly due to the high endogenous level of DNA damage in these cells. The negative 
control in HT1080 cells showed approximately 8% of spontaneous DNA damage, masking possible 
effects of siRNA treatment (Supplemental Fig. S6).  




Knockdown of PINK1, STK38, TRIO, IRAK1, TAOK1 and PNCK genes causes problems during 
mitotic progression  
 
To explore the mechanism(s) by which knockdown of the newly identified CIN genes results in 
chromosome loss, we have performed an  additional set of siRNA-mediated knockdown experiments. To 
rule out cancer cell line-specific phenotypes in HT1080, all experiments were also carried out in non-
transformed retinal pigmented epithelial RPE cells. Changes affecting only HT1080 cells were considered 
specific for this cell line.  
We first measured the mitotic index in RPE and HT1080 cells after siRNA knockdown of PINK1, 
STK38, TRIO, PNCK, IRAK1, TAOK1, BUB1, or BUB1B. In RPE cells, no statistically significant 
increase in the mitotic index was observed (Supplemental Fig. S7A), although we could observe an 
increased number of prophases following STK38 knockdown (Supplemental Fig. S7B). In HT1080 cells, 
we observed a statistically significant increase of the mitotic index, but no statistically significant change 
in the distribution of mitotic phases following knockdown of PINK1 and IRAK1 (Supplemental Fig. S8A-
E). Knockdown of PINK1, STK38, TRIO, TAOK1, and PRKCΕ in RPE cells led to an increased number 
of mitotic abnormalities (Supplemental Fig. S9A), while in HT1080 cells this phenotype was observed 
only after knockdown of STK38 and TAOK1 (Supplemental Fig. S9B). The results of these experiments 
suggest that PINK1, STK38, TRIO, TAOK1, and PRKCΕ genes may be necessary for mitotic progression 
and for maintenance of the cell cycle. Earlier it was shown that the STK38 gene regulates essential 
processes, such as centrosome duplication (Hergovich et al. 2007) and cell cycle/mitotic progression 
(Emoto et al. 2006) and PRKCΕ is involved in mitotic spindle organization (Brownlow et al. 2014; 
Martini et al. 2018) that supports the utility of our  assay for screening new CIN genes.  
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We next characterized in more detail the mitotic defects at the different stages of mitosis 
observed after siRNA knockdown of CIN gene candidates in RPE and HT1080 cells. The cells were 
stained with antibodies against tubulin alpha to visualize the mitotic spindles (Romaniello et al. 2018) and 
against MAD1 (mitotic arrest deficiency 1), an evolutionarily conserved core mitotic checkpoint protein 
that monitors kinetochore-microtubule attachment (Luo et al. 2018). In RPE cells, knockdown of several 
genes revealed a range of mitotic abnormalities (Fig. 7A). Knockdown of STK38 caused problems with 
mitotic spindle formation (absence of the connection to one spindle pole) in prophase. Knockdown of 
PINK1 led to severe problems with chromosome alignment in metaphase, anaphase as well as lagging 
chromosomes in early telophase. Knockdown of TRIO, BUB1, and BUB1B resulted in formation of 
chromatin bridges in anaphase. All these phenotypes can lead to aneuploidy, chromosome damage, and 
micronucleus formation. In HT1080 cells, we also observed a wide range of mitotic abnormalities in 
siRNA knockdown cells (Fig. 7B). Similar to the phenotypes observed in RPE cells, knockdown of 
PINK1 indicated severe problems with spindle formation in metaphase (multiple polarity). Knockdown of 
TRIO correlated with chromosomal loss at anaphase possibly due to kinetochore attachment problems. 
Knockdown of BUB1 and BUB1B showed lagging and bridging chromosomes at anaphase.  
In control siRNA rescue experiments we attempted to exclude that off-target effects might 
account for the most unexpected mitotic abnormalities induced by siRNA-mediated knockdown of these 
genes. We therefore ectopically expressed siRNA resistant cDNAs encoding PINK1 and TRIO in RPE 
cells and tested their ability to rescue the knockdown phenotypes. In both cases, mitotic abnormalities 
caused by knockdown of these genes were rescued by expression of the corresponding cDNAs 
(Supplemental Fig. S10 and Fig. S11). In addition, to evaluate the observed phenotypes, we have 
performed live imaging analyses of PINK1, TRIO, IRAK1, PNCK, TAOK1, and STK38 genes (see 
Supplemental Methods). The analyses confirmed the mitotic defects observed after siRNA knockdown of 
these genes (see Movie S3, Movie S4, Movie S5, Movie S6, Movie S7, Movie S8, and Movie S9). Live 
imaging analyses of PINK1, IRAK1, TRIO, and STK38 showed that formation of lagging chromosomes 
leads to micronuclei formation.  
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In addition, we have prepared CRISPR/Cas9 knockouts (see Supplemental Methods) for the five 
kinases of greatest interest for us, PINK1, TRIO, IRAK1, PNCK, and TAOK1, and determined the 
resulting phenotypes. STK38 was included as a control because, as previously shown, this gene is 
involved in proper chromosome transmission (Hergovich et al. 2007; Chiba et al. 2009; Yan et al. 2015). 
In two cases, for PINK1 and TRIO, we observed the problems with chromosomes alignment and 
kinetochore attachment (Fig. 8). The more pronounced phenotypes scored after siRNA knockdown of 
these genes compared to CRISPR/Cas9-induced gene disruption may be explained by the following 
reasons. In the case of siRNA-mediated knockdown, we analysed problems with chromosome alignment 
within 96 hours of siRNA transfection. In contrast, CRISPR/Cas9-mediated defects were observed after 
cells selection, which takes seven days. Cells may up-regulate compensatory pathways during this 
selection period and cells with the highest levels of abnormalities may not survive.  
After STK38, IRAK1, PNCK, and TAOK1 CRISPR/Cas9-induced gene disruption, we did not 
observe the phenotypes similar to that after siRNA knockdown of these genes (Fig. 8). The same result 
was obtained with the STK38 gene that is required for mitosis progression (Hergovich et al. 2007; Chiba 
et al. 2009; Yan et al. 2015). Therefore, the negative results obtained after CRISPR/Cas9 knockout 
experiments do not exclude that IRAK1, PNCK, and TAOK1 are involved in the control of chromosome 
transmission. It should be noted that there are several publications on side-by-side comparison of 
CRISPR/Cas9 and RNAi screens (Schuster et al. 2019; Morgens et al. 2016; Deans et al.  2016), 
indicating that the two screening technologies may identify different biological categories of genes or 
showed little correlation, which can be partially explained by the identification of distinct essential 
biological processes with each technology. 
To summarize the above experiments, we conclude that five genes, PINK1, IRAK1, PNCK, 
TAOK1, and TRIO may be considered as novel CIN genes involved in the control of chromosome 
transmission in human cells.  
 
Discussion 
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Compared to yeast, where essentially every gene has been checked for its role in chromosome 
transmission, only a moderate fraction of genes that control proper transmission of chromosomes has 
been annotated in humans (Paulsen et al. 2009; Hurov et al. 2010; Hutchins et al. 2010; Neumann et al. 
2010). This difference is mainly due to the development of conceptually simple color colony assays in 
yeast that provided a powerful high-throughput genetic tool to assess the rates of chromosome mis-
segregation and to identify mutants deficient in this process (Spencer et al. 1990). The final list of yeast 
genes involved in controlling chromosome stability consists of 937 genes (Stirling et al. 2012; Duffy et al. 
2016). This catalog of genes revealed a number of human orthologs known to be recurrently 
overexpressed and/or amplified in tumors (Duffy et al. 2016). However, a large number of human CIN 
genes remains to be discovered in humans.  Identification of these genes would be a first step towards 
completing the annotation of genetic loci controlling chromosome transmission in humans. 
 In the current study, we developed a novel high-throughput imaging (HTI) assay for identification 
of genes controlling chromosome transmission in human cells. Our strategy employs a nonessential 
human artificial chromosome, the alphoidtetO-HAC (Nakano et al. 2008), expressing a dual short half-life 
green fluorescent protein dGFP (Sakaue-Sawano et al. 2008). The HAC/dGFP-HTI assay was used to 
screen a siRNA library of human protein kinases and identified five new candidate CIN genes, i.e. 
PINK1, TRIO, IRAK1, PNCK, and TAOK1, knockdown of which leads to elevated frequencies of 
binucleated cells with micronuclei and chromatin bridges (both measures of genome damage and 
chromosome instability). All these genes have previously been associated with human disorders. Earlier 
biochemical and genetic studies revealed that PINK1, which has been associated to Parkinson's disease, 
works together with Parkin in the a pathway involved in mitochondrial quality control (Pickrell and 
Youle 2015). TRIO is an essential gene with a prominent role in the development of the nervous system. 
TRIO expression is significantly increased in different types of tumors and it has been proposed to 
participate in oncogenesis (Schmidt and Debant 2014). IRAK1 is associated with pediatric systemic Lupus 
Erythematosus and Lubs X-linked mental retardation syndrome (Gottipati et al. 2008). PNCK is 
 Cold Spring Harbor Laboratory Press on September 17, 2019 - Published by genome.cshlp.orgDownloaded from 
  16
overexpressed in a subset of breast tumors and linked to Jervell and Lange-Nielsen Syndrome 1 (Wu et al. 
2013). TAOK1 is involved in the cell cycle and signaling by Rho GTPases pathways (Raman et al. 2007). 
To our knowledge, neither PINK1, TRIO, IRAK1, PNCK, or TAOK1 genes have previously been linked to 
CIN. It is known that in yeast a large fraction of CIN genes has been originally identified as those that 
function in pathways with unknown connections to chromosome segregation (e.g. tRNA synthesis, GPI- 
anchors and secretion) (Yuen et al. 2007; Stirling et al. 2011; Stirling et al. 2012). 
 Here, we went on to show that siRNA knockdown of PINK1, STK38, TRIO, TAOK1, and PRKCΕ 
causes problems during mitosis progression. More specifically, knockdown of PINK1 leads to severe 
defects in metaphase and anaphase chromosome alignment as well as lagging chromosomes in telophase 
(Supplemental Fig. S12). Knockdown of STK38 was associated with problems in mitotic spindle 
formation in prophase while knockdown of TRIO, BUB1, and BUB1B was associated with formation of 
chromatin bridges in anaphase (Supplemental Fig. S12). All these phenotypes can lead to aneuploidy, 
chromosome damage and micronucleation formation. We also demonstrated that knockdown of PINK1, 
TRIO, STK38, BUB1, and BUB1B induces formation of DSBs that may also cause chromosome 
instability.  
Our results are supported by bioinformatical data. The NCI-60 cell lines derived from nine tissues 
of origin types of cancer have been characterized for multiple parameters, including transcript expression 
(Reinhold et al. 2012; Reinhold et al. 2015). Bioinformatical analysis of the NCI-60 database using NCI-
60 expression data from five different microarray platforms (see Methods) showed a significant 
correlation between down regulation of PINK1, TRIO, IRAK1, BUB1, and BUB1B and an increased level 
of cytogenetic alterations (Supplemental Table S5).  
In addition, we constructed a gene interaction network map that represents potential functional 
relationships among the CIN kinases, PINK1, STK38, TRIO, IRAK1, PNCK, and TAOK, and the 
proteins involved in cell division and cell cycle regulation (see Supplemental Fig. S13). The most 
frequent relationship was protein-protein interactions (54), followed by activation (27) and 
phosphorylation (21) (Supplemental Table S6). Knowledge about interacting proteins is crucial for 
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understanding their biological functions, which can be done via studying networks of these interactions. 
Also, this network may also help in planning the future experiments to shed light on the role of these 
kinases in the complex process of chromosome transmission.  
  Identification of novel CIN genes is crucial for understanding the molecular mechanisms of 
mitotic regulation. Analysis of a role of each CIN gene identified in this study in the complex process of 
chromosome transmission will be the subject of future investigations. In addition, given that CIN 
represents a vulnerability that can be exploited as a therapeutic avenue for treatment of cancer (Janssen et 
al. 2009; Colombo and Moll 2011; Bakhoum and Compton 2012; Giam and Rancati 2015), the CIN genes 
identified in this study introduce potential biomarkers that may expedite the development of new 
therapeutic strategies that target cancer cells. In the future, the HAC/dGFP-HTI assay can be applied for 
screening different siRNA libraries (such as those targeted towards cell cycle regulation, DNA damage 
response, epigenetics, transcription factors) and for genome-wide screening to identify other genes 
involved in CIN. We admit that some genes may be missed during siRNA libraries screening. It can be 
due to a high cytotoxic effect of some siRNAs as has been observed for siRNA against AURKB in this 
study or a high stability of the protein such as CENPA. For such genes other approaches can be applied. 
For example, gene overexpression was used for identification of CIN genes (Duffy et al. 2016). 
Nevertheless the fact that this assay can identify genes previously unknown to have any connection with 
chromosome segregation suggests that further characterization of these novel CIN genes may reveal 




Construction of the p264-GFP-CDT1-GFP-GEMININ vector 
 
At the first step of construction, the 1,043 bp and 1,091 bp fragments of the cell cycle sensors, GFP-
CDT1 and GFP-GEMININ, containing the coding region of the green fluorescent protein (GFP) were 
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PCR-amplified from GFP-CDT1 and GFP-GEMININ synthetized gBlocks (IDT, USA) using the 
corresponding primers (Supplemental Table S7). The primers contain EcoRI restriction sites at the 5’ends 
of  the fragments, which are necessary for the further steps of construction. The amplified products were 
ligated with the EcoRI-digested pCX vector producing the pCX-GFP-CDT1 vector of 5,813 bp in length 
and pCX-GFP-Geminin vector of 5,861 bp in length. Each sensor and a green fluorescent protein are 
under the SV40 virus promoter (see Supplemental Fig. S1A,B). The second step of construction included 
restriction of the pCX-GFP-CDT1 and pCX-GFP-Geminin vectors with BamHI/SpeI and AvrII/SpeI, 
respectively, that produced two fragments, 465 bp and 3,700 bp in length, correspondingly. The third step 
of construction included ligation of the BamHI/SpeI pCX-GFP-CDT1 fragment with the linearized p264 
vector (Lee et al. 2013b) producing the p264_GFP-CDT1vector (Supplemental Fig. S1C). The fourth step 
of construction included ligation of the AvrII/SpeI pCX-GFP-Geminin fragment with the AvrII-digested 
p264_GFP-CDT1 vector producing p264_GFP-CDT1-GFP-GEMININ vector (Supplemental Fig. S1D). 
The final p264-GFP-CDT1-GFP-GEMININ vector contains the open reading frames of GFP-CDT1 and 
GFP-Geminin, each under control of the CAG promoter that allows their expression in hamster CHO and 
human HT1080 cells. The final p264-GFP-CDT1-GFP-GEMININ vector contains a single loxP site and a 
3’ part of the HPRT gene flanked by the cHS4 insulators that is essential for its loading into the 
alphoidtetO-HAC by Cre-lox-mediated recombination.  Primers used for plasmids construction are listed in 
Supplemental Table S7. 
 
Loading of p264-GFP-CDT1-GFP-GEMININ vector into alphoidtetO-HAC in hamster CHO cells 
 
 2 μg of the p264-GFP-CDT1-GFP-GEMININ vector and 0.2 μg of the Cre expressing pCpG-iCre vector 
DNA were co-transfected into HPRT-deficient hamster CHO cells containing the alphoidtetO-HAC with a 
single loxP site by lipofection using X-tremeGENE 9 (Roshe). HPRT-positive colonies were selected 
after 2-3 weeks growth in HAT medium. For each experiment, from 10 to 15 clones were usually 
selected. The correct loading of the p264-GFP-CDT1-GFP-GEMININ vector in the HAC was confirmed 
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by PCR using a specific pair of primers that diagnoses reconstitution of the HPRT gene (Supplemental 
Table S7).  The final construct was designated as HAC/dGFP (Supplemental Fig. S2). 
 
Microcell-mediated chromosome transfer (MMCT)  
 
MMCT transfer of HAC/dGFP from hamster CHO cells to human HT1080 cells was performed as 
described previously (Liskovykh et al. 2016).  
 
FISH analysis  
 
The presence of the HAC in an autonomous form was confirmed by FISH analysis as previously 
described (Nakano et al. 2008; Iida et al. 2010; Kim et al. 2011) (see also Supplemental Methods for 
details).  
 
Generation of HT1080/pCX-CDT1-GFP and HT1080/pCX-GEMININ-GFP cell lines for time lapse 
microscopy  
 
Human HT1080 cells were transfected with the pCX-CDT1-GFP and pCX-GEMININ-GFP vectors 
described above (see Supplemental Fig. S1A,B). 150,000 cells per one well of 6-well plate were seeded 
and transfected by 2 µg of each plasmid using a standard protocol provided by DNA Transfection 
Reagent X-tremeGENE 9 (Rosh). To select the cells with stable GFP expression, we used MoFlo Astrios 
EQ cell sorter (Beckman Coulter). The cells were sorted and seeded on 96-wells plate. The clones with 
the brightest GFP expression were taken for the time lapse microscopy experiment.  
 
Time lapse microscopy 
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HT1080 cells containing HAC/dGFP and HT1080 cells transfected by either pCX-CDT1-GFP or pCX-
GEMININ-GFP vectors were seeded (1000 cells per cm2) on a separate µ-Slide 8 Well (ibidi) in DMEM 
(Thermo Fisher Scientific) supplemented with 10% (v/v) fetal bovine serum (Clontech Laboratories, Inc.) 
at 37oC in 5% CO2 atmosphere. Time-lapse imaging was performed using the FV1200 confocal laser 
scanning microscopy system equipped with the objective lens (Olympus, UPLSAPO 20x NA. = 0.75). 
405 nm LD Laser with Integrated Transmitted Light Photomultiplier Detector and 488 nm Argon laser 
with High-Sensitivity Detector (GaAsP) were used. To avoid cross detection, the images were acquired 
sequentially at 488 nm (Argon) and 405 nm (LD). The transmitted light signal and GFP fluorescence 




The HT1080 containing HAC/dGFP cells were grown for 96 hr after transfection, harvested by trypsin-
treatment and resuspended in PBS containing 3 µM DRUQ7. Flow cytometry was performed on an BD 
Accuri C6. All samples were vortexed immediately prior to flow cytometry examination. Fluorescence of 
GFP positive cells was measured by the 488 nm laser and detected at 510 nm. The death cells were 
counted by DRUQ7 fluorescence excited by the 640 nm laser and detected at 722 nm. Samples were 
acquired in at least three separate triplicates for 30 sec or 1×104 events (at minimum). Flow cytometry 
analysis was primarily performed using C-Flow Plus (BD Biosciences).  
 
siRNA transfection using 24-well plate 
  
The genes of interest were knockdown using siRNAs (Supplemental Table S1).  siRNAs were purchased 
from Dharmacon (Lafayette, CO). For siRNA treatment, 12.5×103 / well cells were seeded in 24-well 
plates before a day of the experiment. Cells were transfected with each siRNA (a working concentration 
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17 nM) using Lipofectamine RNAiMAX (Thermo Fisher Scientific) followed by the manufacturer’s 
protocol. Cells were grown without blasticidine for 96 hr after transfection. Silencing efficiency of each 
protein was monitored by Western blot analysis (see Supplemental Table S8). After 96 hr, the cells were 
collected and analyzed by flow cytometry to detect the proportion of cells that reactivated GFP 
fluorescence or lost GFP signal. All the experiments were carried out in 3 triplicates.  
 
siRNA transfection using 24-well plates for rescue experiments 
  
The rescue experiments were carried out as recommended in description to Lipofectamine RNAiMAX 
(Thermo Fisher Scientific) followed by the manufacturer’s protocol. The genes of interest were depleted 
using siRNAs (Supplemental Table S1). siRNAs were purchased from Dharmacon (Lafayette, CO). For 
siRNA treatment, 12.5×103 / well cells were seeded in 24-well plates before a day of the experiment. 
Cells were transfected with each siRNA (a working concentration of 12 nM) using Lipofectamine 
RNAiMAX (Thermo Fisher Scientific). To complement siRNA effect, co-transfection of siRNA and 
cDNA resisted to siRNA was performed (for PINK1 cDNA from GeneScript cat. #OHu25380 and for 
TRIO cDNA from GeneScript cat. #OHu25435 were used). Cells were grown for 96 hr after transfection. 
After 96 hr, the cells were fixed, immunostained and analyzed by confocal microscopy. All the 
experiments were carried out in triplicates.  
 
siRNA oligo library preparation 
 
High-throughput imaging of siRNA screen was performed in 384-well plates. The library used in 
screening includes siRNA oligos targeting 720 human genes annotated to be kinases and phosphatases (4 
pooled siRNA oligos per gene, G-003705 Human Phosphatase Lot 09126 and G-003505 Human Protein 
Kinase Lot 09174, On-Target Plus, Dharmacon). siRNA oligos of a negative, non-targeting control 
siRNA (Neg siRNA Control Pool #2, Dharmacon, D-001206-14-20), a positive control siRNA pool 
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(PLK1, Dharmacon, M-003290-01) and two positive biological controls of siRNA pools (PRKCE, 
Dharmacon;  SKA3, customer synthesized) at the same concentration were included in eight replicates for 
each plate. 2 μl per well of siRNA of each oligo pool at the concentration of 1.25 μM were spotted at the 
bottom of 384-well CellCarrier Ultra imaging plate (PerkinElmer, 6057300) using a PerkinElmer Janus 
Automated liquid handler. The 384-well plates were air dried under a sterile laminar flow for at least 30 
min, sealed, and then stored at -80OC until transfection. 
 
siRNA oligo library transfection 
 
At the day of transfection, the plates were equilibrated at RT for at least 30 min and then spun at 4,000 
rpm for 2 min. 25 μl of Opti-MEM (Thermo Fisher Scientific, 51985034) containing 0.075 μl of pre-
mixed Lipofectamine RNAiMax (Thermo Fisher Scientific, 13778150) was dispensed in each well of the 
imaging plate using Thermo Fisher Scientific Multidrop Combi and incubated at RT for 30 min 
(Supplemental Fig. S14). 25 μl of 450 cells (18 cells/μl) in DMEM, 20% FBS were added to the siRNA 
oligo/RNAiMax mix, incubated at RT for 30 min and then incubated for 96 hr at 37OC. The final 
concentration of siRNA oligos in the medium was 50 nM. 
 
Fixation and fluorescence staining 
 
Cells were fixed by adding 50 μl of 8% paraformaldehyde (PFA) directly to the media, incubated for 15 
min at RT, washed 3 times with 50 μl of PBS and then incubated with 50 μl of DAPI (0.1 μg/ml) in PBS 
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Fixed and stained plates were imaged using a Yokogawa CV7000S spinning disk confocal microscope 
with Olympus 40x (NA 0.95) PlanApoChromat lens, an emission 405/488/561/640 dichroic mirror and a 
16-bit sCMOS camera (2550×2160 pixels) with pixel binning set to 2×2. For the DAPI channel, a 405 nm 
laser source and a 445/45 nm bandpass acquisition filter were used. For the GFP channel, a 488 nm laser 
source and a 525/50 nm bandpass acquisition filter were used. The DAPI and GFP channels were 
acquired sequentially at a single focal plane in 9 fields of view per well. Images were saved as 16-bit 
TIFF files.  
 
High-content image analysis 
 
TIFF files generated by the CV7000S microscope were imported and analyzed using PerkinElmer 
Columbus 2.7. The DAPI channel was used to segment a nuclear ROI mask, which was then used to 
measure the mean fluorescence intensity in the nucleus in the GFP channel. Nuclei touching the image 
borders and nuclei with a roundness value of less than 0.7, often representing nuclear segmentation errors, 
were excluded from the subsequent analysis steps. The cells with values of GFP mean fluorescence 
intensity < 100 A.U., an empirically determined threshold that was kept constant for all plates in the 
screen, were classified as GFP-. The percentage of GFP- cells was used as a proxy for measuring HAC 
loss. Well-level data were exported as tab-separated text files.  
 
Calculation of doubling time of the HAC/dGFP-containing HT1080 cells 
 
HT1080 cells containing HAC/dGFP cells (6,500 cells/cm2) were seeded in a 6-well tissue culture plate 
and cultivated in the presence of 10 µg/ml blasticidin for 210 hours using Cell-IQ high-content in vivo 
imaging system equipped with 20x LUCPlanFLN Olympus Objective and Hamamatsu CCD camera. The 
growth curve was performed by time-lapse cell population analysis recognizing each cell by its peculiar 
image using a phase-contrast microscopy utilizing computer vision as well as fluorescent signal analysis 
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to identify GFP positive cells. The growth curve was generated automatically using Cell-IQ Analyzer 
software after the image library was done and each cell was marked with a specific dot marker plotted on 
the image mask for an operator's visual control (Supplemental Fig. S15). 
  
Calculation of the rate of HAC loss induced by siRNA-mediated knockdown of a target gene 
 
The rate of HAC loss  was calculated as previously described (Lee et al. 2013a) with some modifications 
(see Supplemental Methods and Supplemental Table S9). 
 
Cytokinesis-block micronucleus assay 
 
Cytokinesis-block micronucleus assay was performed as described (Fenech 2007) with minor changes 
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Figure 1. Experimental design of a high-throughput imaging (HTI) human artificial chromosome (HAC)-
based assay to identify novel CIN genes via siRNA screening. (A) The assay is based on the use of 
alphoidtetO-HAC (Nakano et al. 2008) (or Tet-O HAC) expressing a dual short half-life green fluorescent 
protein GFP-CDT1-GFP-GEMININ. Such HAC was named as HAC/dGFP. DNA in situ fluorescence 
hybridization (FISH) on a metaphase spread of HT1080 cells carrying HAC/dGFP using a probe against 
the HAC (see Methods for details) and a schematic representation of the HAC/dGFP are shown. (B) A 
schematic representation of the dGFP reporter stability during different phases of the cell cycle in 
HT1080 cells. Cells that express cell cycle sensors CDT1 and GEMININ fused with GFP display green 
fluorescence during the entire cell cycle. (C-D) Schematics of siRNA screening using HAC/dGFP-HTI 
assay to identify CIN genes.  HT1080 cells carrying HAC/dGFP are transfected with a non-targeting 
control siRNA or with siRNA against a gene of interest, knockdown of which induces HAC/dGFP loss 
(indicated as siRNA1 or siRNA2), in a 384-well imaging plate. Cells are fixed and the nuclear 
fluorescence in the GFP channel is measured using HTI. Cells transfected with siRNA against CIN genes 
display an increase of HAC/dGFP loss compared to the negative (non-targeting) control siRNA treatment.  
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Figure 2. Validation of the HAC/dGFP-HTI assay. Measurement of the proportion of GFP- positive and 
GFP-negative cells in HT1080 human cells carrying HAC/dGFP treated with a set of siRNAs designed to 
knockdown known genes essential for chromosomal transmission using flow cytometry (FACS) (A), 
high-throughput imaging (HTI) (B) and fluorescence in situ hybridization (FISH) (C). (D) The formula 
used to determine the rate of HAC loss per generation after siRNA treatment (see Methods for details). 
(A-C) The rate of HAC/dGFP loss after treatment with a set of siRNAs against CENPA, AURKB, 
CENPN, SKA3 and OIP5 as measured by FACS (A), HTI (B) and FISH (C). The error bars indicate 
standard deviation. Knockdown of SKA3 and OIP5 shows the highest effect on HAC/dGFP loss. Red 
asterisks indicate siRNA treatment that results in statistically significant difference (p<0.05; done by t-
test) when compared to a negative control (scr. siRNA or non-targeting siRNA). (E) Western blot analysis 
confirming silencing efficiency of CENPA, CENPN, CENPE, AURKB, OIP5 and SKA3 proteins (see 
Supplemental Table S8) after siRNA-mediated knockdown of the genes.  
 
 
Figure 3. Mitotic stability of the HAC/dGFP in human HT1080 cells treated with a set of siRNAs against 
28 human orthologs of yeast CIN genes. A list of gene orthologs selected for the analysis includes 
CNOT6, NAT10, PIGB, TANGO6, PIGU, PIGs, GPN2, PRC1, IPO11, CIAO2B, NPEPPS, RTN2, UAP1, 
MSI1, AP2B1, PPIP5K1, WDR76, C12orf10, PLCD3, MUC4, NF1, RAB1A, MEMO1, SMARCAD1, 
RPL13, XAB2, MYO5B, and PRKCΕ genes. Mitotic stability of HAC/dGFP after knockdown of a target 
gene was measured by flow cytometry (FACS) (A) and high-throughput imaging (HTI) (B). Among 28 
genes analyzed, the strongest effect on HAC/dGFP stability was revealed after cells treatment by siRNA 
against PRKCΕ (green color and red asterisk). siRNAs against OIP5 and SKA3 were used as positive 
controls for FACS and HTI experiments, correspondingly, and scrambled siRNA (non-targeting siRNA) 
was used as a negative control. Red asterisks indicate statistical significance (p<0.05; done by t-test) 
when compared to a negative control. (C) Western blot analysis monitoring silencing efficiency of 
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NAT10, PIGB, PIGS, PRC1, IPO11, CIAO2B, MSI1, AP2B1, WDR76, PICD3, MUC4, NF1, RAB1A, 
MEMO1, RPL13, XAB2, and PRKCΕ proteins (see Supplemental Table S8) after siRNA-mediated 
knockdown of these genes.  
 
Figure 4. Mitotic stability of HAC/dGFP in human HT1080 cells treated with siRNA library against 
protein kinases. (A)  Scatter plot showing a distribution of siRNAs against protein kinases based on Z-
score.  The genes marked in blue and positioned between a negative control (scr. siRNA in green) and the 
highest score are suitable for the next step of the analysis. SKA3 and PRKCE were used as positive 
controls (in red). (B) Mitotic stability of HAC/dGFP in human HT1080 cells treated with siRNA library 
against protein kinases. siRNAs against SKA3 and PRKCΕ were used as positive controls and a scrambled 
siRNA (scr. siRNA) as a negative control. Among 714 genes analyzed, the strongest effect on HAC loss 
was shown by siRNAs against ITPKB, IRAK1, MYLK, TNK2, STK38, BLK, MAPK7, FRK, TRIO, STK11, 
CRIM1, CSK, PDXK, PHKG1, KSR2, CAMK2G, PHKB, CSNK1G2, MYLK4, NYD-SP25, RBKS, TTBK1, 
PNCK, PINK1, BTK, HIPK2, BUB1, ATM, BUB1B, TAOK1, and NEK9 (marked by different intensity of 
red color). Red asterisks indicate statistical significance (p<0.05; done by t-test) when compared to a 
negative control. (C) Western blot analysis confirming silencing efficiency of ATM, BLK, BTK, 
CAMK2G, CSK, HIPK2, ITPKB, MYLK, PDXK, PHKB, PHKG1, STK11, MYLK4, NEK9, and TNK2 
proteins (see Supplemental Table S8) after siRNA-mediated knockdown of the genes. 
 
Figure 5. The reconfirmed final list of the CIN gene candidates. (A) The rate of HAC/dGFP loss after 
knockdown of gene-candidates was measures by three independent approaches: i) after siRNA-mediated 
knockdown using a pull of siRNAs (in brown). The rate was measured by HTI as a proportion of non-
fluorescent cells); ii) after knockdown of the target gene using one single siRNA sequence (in blue). The 
rate was measured by HTI; iii) after knockdown of a target gene using one independent siRNA sequence 
(in green). The rate was measured by FISH. The red asterisks indicate statistical significance (p<0.05; 
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done by t-test) when compared to a negative control (scr. siRNA or non-targeting siRNA). (B) Silencing 
efficiency of each protein was monitored by Western blot analysis (see Supplemental Table S8).  
 
Figure 6. (A-D) Micronuclei (MNi) and nucleoplasmic bridges (NPBs) formation in RPE cells after 
knockdown of one of the following genes: TRIO, BUB1, BUB1B, PNCK, IRAK1, TAOK1, PRKCΕ, 
STK38, and PINK1. (A) The percentage of the binucleated cells without abnormalities. (B) The percentage 
of NPBs. (C) The percentage of MNi. Scrambled siRNA (non-targeting siRNA) was used as a negative 
control.  Error bars correspond to a standard deviation (SD) of four replicates. Red asterisks indicate 
statistical  significance when compared to the control [calculated by Fisher's exact test with Bonferroni 
correction for multiple testing (p<0.0011)]. (D) A normal binucleated cell; a binucleated cell containing 
three MNi; a cell containing one NPB. White arrows point to  MNi and NPB. The cells were stained with 
DAPI and Eosin Y. (E-F) Immunostaining of  double-stranded breaks (DSBs) with an antibody against 
gamma H2AX in interphase of RPE cells after knockdown of PINK1, TRIO, BUB1, STK38, BUB1B, 
TAOK1, PRKCΕ, PNCK, and IRAK1 genes. (E) Examples of immunostaining of the cells. Red signals – 
gamma H2AX staining as a marker for DSBs. Accumulation of gamma H2AX foci occurred at day 3 in 
all cases. White arrows point to  the cell nuclei with gamma H2AX signals. (F) A statistical effect of 
gamma H2AX foci after knockdown of a target gene. A statistical effect was determined at day 3. For 
PINK1, TRIO, BUB1, and  STK38 genes, statistically significant (Fisher’s exact test: p-value; 2-tailed) 
results when compared to a negative control  (scr. siRNA or non-targeting siRNA) are indicated with 
square brackets and red asterisks.  
 
Figure 7. Analysis of localization of tubulin alpha and MAD1 at the different stages of mitosis after 
knockdown of STK38, IRAK1, PINK1, PNCK, PRKCΕ, TRIO, BUB1, BUB1B, and TAOK1 genes in RPE 
(A) and HT1080 (B) cells. NC stands for a negative control. Staining by antibodies against tubulin alpha 
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is marked in red, against MAD1 in white. Green squares and yellow arrows point to the observed mitotic 
abnormalities.  
 
Figure 8. CRISPR/Cas9 disruption of the PINK1, TRIO, IRAK1, PNCK,  STK38, and TAOK1 genes. (A) 
Percentage of abnormal mitoses counted after CRISPR/Cas9 disruption of the PINK1, TRIO, IRAK1, 
PNCK,  STK38, and TAOK1 genes. For statistical significance Fisher’s exact test was applied. Red 
asterisk indicates statistical significance (p<0.05) in comparison with negative control (Parental cells). 
About 150 mitotic events were analyzed. (B) Immunostaining of the cells after  CRISPR/Cas9 knockout 
against tubulin alpha (red) counterstained with DAPI to observe mitotic abnormalities. Yellow arrows 
point to the identified mitotic abnormalities. (C) Western blot analysis confirming absence of PINK1, 
TRIO, IRAK1, PNCK,  STK38, and TAOK1 proteins after CRISPR/Cas9-mediated knockout of these 
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